Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) Capital Expenditures: 2011-2025

Historic Capital Expenditures for Sonoma Pharmaceuticals (SNOA) over the last 14 years, with Mar 2025 value amounting to $80,000.

  • Sonoma Pharmaceuticals' Capital Expenditures fell 50.00% to $129,000 in Q1 2013 from the same period last year, while for Mar 2013 it was $257,000, marking a year-over-year decrease of 23.51%. This contributed to the annual value of $80,000 for FY2025, which is 3900.00% up from last year.
  • According to the latest figures from FY2025, Sonoma Pharmaceuticals' Capital Expenditures is $80,000, which was up 3,900.00% from $2,000 recorded in FY2024.
  • In the past 5 years, Sonoma Pharmaceuticals' Capital Expenditures ranged from a high of $269,000 in FY2023 and a low of $2,000 during FY2024.
  • Moreover, its 3-year median value for Capital Expenditures was $80,000 (2025), whereas its average is $117,000.
  • In the last 5 years, Sonoma Pharmaceuticals' Capital Expenditures plummeted by 99.26% in 2024 and then surged by 3,900.00% in 2025.
  • Sonoma Pharmaceuticals' Capital Expenditures (MRY) stood at $179,000 in 2021, then fell by 23.46% to $137,000 in 2022, then skyrocketed by 96.35% to $269,000 in 2023, then plummeted by 99.26% to $2,000 in 2024, then skyrocketed by 3,900.00% to $80,000 in 2025.
  • Its last three reported values are $80,000 in FY2025, $2,000 for FY2024, and $269,000 during FY2023.